Pharmaceutical composition for inhalation containing CR 2039 (An

Details Pharmaceutical composition for inhalation containing CR 2039 (An Pharmaceutical composition for inhalation containing CR 2039 (An

1998-08-06

1999-11-02

Reamer, James H.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

514381, A61K 914, A61K 3141

Patent

active

059765763

ABSTRACT:
A pharmaceutical composition comprising, as active ingredient, N-4-(1H-tetrazol-5-yl)phenyl-4-(1H-tetrazol-5-yl)benzamide disodium salt (CR 2039, Andolast) or another pharmaceutically-acceptable salt thereof and a flavoring, and optionally including a pharmaceutically-acceptable inert carrier and/or a pharmaceutically-acceptable sweetener, the composition being suitable for administration by oral inhalation.

REFERENCES:
patent: 5232937 (1993-08-01), Makovec et al
patent: 5292750 (1994-03-01), Yoshikuni et al.
patent: 5453368 (1995-09-01), Tresco et al.
patent: 5648096 (1997-07-01), Grander et al.
patent: 5741168 (1998-04-01), Stroh et al.
patent: 5780051 (1998-07-01), Eswara et al.
patent: 5855913 (1999-01-01), Hanes et al.
Revel et al, European Journal of Pharmacology, 229:45-53 (1992).

Affiliated with

Also associated with

Rating

Pharmaceutical composition for inhalation containing CR 2039 (An does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for inhalation containing CR 2039 (An, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for inhalation containing CR 2039 (An will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2131689